VIBATIV (telavancin HCl)
AGENTS TO TREAT RESISTANT GRAM POSITIVE ORGANISMS · STAPHYLOCOCCUS NOSOCOMIAL PNEUMONIA ·+6
CUMBERLAND PHAR
Drug class
Telavancin
Telavancin is not a distinct therapeutic drug class, but rather a specific active pharmaceutical ingredient belonging to the lipoglycopeptide class of antibacterial agents. Read more about Telavancin
1 drugs in this class 1 manufacturers
Drugs in Telavancin
Filter & compare in the drug finder →
Opens the drug finder with Telavancin preselected. Add indication or manufacturer filters there.
Telavancin is not a distinct therapeutic drug class, but rather a specific active pharmaceutical ingredient belonging to the lipoglycopeptide class of antibacterial agents.
As a semisynthetic derivative of vancomycin, it exerts bactericidal activity through a dual mechanism: inhibiting late-stage bacterial cell wall peptidoglycan synthesis and disrupting the bacterial cell membrane potential and permeability.
Clinically, it is utilized as an intravenous therapy primarily directed against serious Gram-positive infections, including methicillin-resistant *Staphylococcus aureus* (MRSA).
Its established therapeutic indications encompass complicated skin and skin structure infections as well as hospital-acquired and ventilator-associated bacterial pneumonia when alternative treatment options are unsuitable.
-
inva.com
Telavancin is not a distinct therapeutic drug class, but rather a specific active pharmaceutical ingredient belonging to the lipoglycopeptide class of antibacterial agents As a semisynthetic derivative of vancomycin, it exerts bactericidal activity through a dual mechanism: inhibiting late-stage bacterial cell wall peptidoglycan synthesis and disrupting the bacterial cell membrane potential and permeability Its established therapeutic indications encompass complicated skin and skin structure inf...
-
nih.gov
Telavancin is not a distinct therapeutic drug class, but rather a specific active pharmaceutical ingredient belonging to the lipoglycopeptide class of antibacterial agents
-
nih.gov
As a semisynthetic derivative of vancomycin, it exerts bactericidal activity through a dual mechanism: inhibiting late-stage bacterial cell wall peptidoglycan synthesis and disrupting the bacterial cell membrane potential and permeability
-
vibativ.com
As a semisynthetic derivative of vancomycin, it exerts bactericidal activity through a dual mechanism: inhibiting late-stage bacterial cell wall peptidoglycan synthesis and disrupting the bacterial cell membrane potential and permeability
-
vibativ.com
Clinically, it is utilized as an intravenous therapy primarily directed against serious Gram-positive infections, including methicillin-resistant *Staphylococcus aureus* (MRSA) Its established therapeutic indications encompass complicated skin and skin structure infections as well as hospital-acquired and ventilator-associated bacterial pneumonia when alternative treatment options are unsuitable
-
nih.gov
Clinically, it is utilized as an intravenous therapy primarily directed against serious Gram-positive infections, including methicillin-resistant *Staphylococcus aureus* (MRSA)
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.